Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Conjunctival Melanoma—Clinical Pearls Now, Hope for the Future

Conjunctival Melanoma—Clinical Pearls Now, Hope for the Future Conjunctival Melanoma and Features Associated With BRAF Mutations Original Investigation Research 30. Menzies AM, Haydu LE, Visintin L, et al. 32. Chang DZ, Panageas KS, Osman I, Polsky D, colorectal cancer and melanoma: a systematic Distinguishing clinicopathologic features of Busam K, Chapman PB. Clinical significance of BRAF review and meta-analysis. PLoS One. 2012;7(10): patients with V600E and V600K BRAF-mutant mutations in metastatic melanoma. J Transl Med. e47054. doi:10.1371/journal.pone.0047054. metastatic melanoma. Clin Cancer Res. 2012;18(12): 2004;2(1):46. 3242-3249. 33. Safaee Ardekani G, Jafarnejad SM, Tan L, Saeedi 31. Yu GP, Hu DN, McCormick S, Finger PT. A, Li G. The prognostic value of BRAF mutation in Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135(6): 800-806. Invited Commentary Conjunctival Melanoma—Clinical Pearls Now, Hope for the Future Dan S. Gombos, MD In this issue of JAMA Ophthalmology, Larsen and colleagues patient mortality. In my opinion, for these reasons an exci- performed a retrospective review of primary conjunctival mela- sional biopsy should be the preferred approach for the vast ma- nomas; the cohort represented a 50-year retrospective assess- jority of suspicious conjunctival lesions and any surface neo- ment of specimens identified in the Eye Pathology Institute plasm where the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

Conjunctival Melanoma—Clinical Pearls Now, Hope for the Future

JAMA Ophthalmology , Volume 133 (11) – Nov 1, 2015

Loading next page...
 
/lp/american-medical-association/conjunctival-melanoma-clinical-pearls-now-hope-for-the-future-xKR9l1V9GX
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2015.3564
pmid
26426717
Publisher site
See Article on Publisher Site

Abstract

Conjunctival Melanoma and Features Associated With BRAF Mutations Original Investigation Research 30. Menzies AM, Haydu LE, Visintin L, et al. 32. Chang DZ, Panageas KS, Osman I, Polsky D, colorectal cancer and melanoma: a systematic Distinguishing clinicopathologic features of Busam K, Chapman PB. Clinical significance of BRAF review and meta-analysis. PLoS One. 2012;7(10): patients with V600E and V600K BRAF-mutant mutations in metastatic melanoma. J Transl Med. e47054. doi:10.1371/journal.pone.0047054. metastatic melanoma. Clin Cancer Res. 2012;18(12): 2004;2(1):46. 3242-3249. 33. Safaee Ardekani G, Jafarnejad SM, Tan L, Saeedi 31. Yu GP, Hu DN, McCormick S, Finger PT. A, Li G. The prognostic value of BRAF mutation in Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135(6): 800-806. Invited Commentary Conjunctival Melanoma—Clinical Pearls Now, Hope for the Future Dan S. Gombos, MD In this issue of JAMA Ophthalmology, Larsen and colleagues patient mortality. In my opinion, for these reasons an exci- performed a retrospective review of primary conjunctival mela- sional biopsy should be the preferred approach for the vast ma- nomas; the cohort represented a 50-year retrospective assess- jority of suspicious conjunctival lesions and any surface neo- ment of specimens identified in the Eye Pathology Institute plasm where the

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Nov 1, 2015

References